The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
When to intervene to increase use of adjuvant hormone therapy among women with hormone-sensitive breast cancer.
V. P. Quinn
No relevant relationships to disclose
J. A. Strauss
No relevant relationships to disclose
J. E. Schottinger
No relevant relationships to disclose
C. T. Cheetham
No relevant relationships to disclose
R. Haque
No relevant relationships to disclose